Related Experiment Video
Updated: Sep 26, 2026
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Evidence for lipopolysaccharide-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like
Rajiv K Saxena1, Val Vallyathan, Daniel M Lewis
1School of Life Sciences, Jawaharlal Nehru University, New Delhi 110 067, India. rksaxena@mail.jnu.ac.in
Abstract:
Effect of lipopolysaccharide (LPS) on RAW264.7 macrophage cell line was studied. LPS-treated RAW264.7 cells increased in cell size and acquired distinct dendritic morphology. At the optimal dose of LPS (1 mg/ml), almost 70% RAW264.7 cells acquired dendritic morphology. Flow cytometric studies indicate that the cell surface markers known to be expressed on dendritic cells and involved in antigen presentation and T cell activation (B 7.1, B 7.2, CD40, MHC class II antigens and CD1d) were also markedly upregulated on LPS-treated RAW 264.7 cells. Our results suggest the possibility that LPS by itself could constitute a sufficient signal for differentiation of macrophages into DC-like cells.
Insights
Lipopolysaccharide (LPS) treatment transforms RAW264.7 macrophages into dendritic cell-like cells, enhancing their potential for antigen presentation. This study shows LPS alone can induce macrophage differentiation into dendritic cells.
Area of Science:
- Immunology
- Cell Biology
Background:
- Macrophages are key immune cells.
- Dendritic cells are crucial for T cell activation.
Purpose of the Study:
- To investigate the effect of lipopolysaccharide (LPS) on RAW264.7 macrophage differentiation.
- To determine if LPS can induce macrophages to adopt dendritic cell characteristics.
Main Methods:
- RAW264.7 macrophage cell line treated with varying doses of LPS.
- Morphological analysis to assess cell shape changes.
- Flow cytometry to evaluate cell surface marker expression.
Main Results:
- LPS treatment increased RAW264.7 cell size and induced a dendritic morphology in nearly 70% of cells at optimal dosage.
- Upregulation of dendritic cell markers (B7.1, B7.2, CD40, MHC class II, CD1d) was observed on LPS-treated cells.
- These markers are involved in antigen presentation and T cell activation.
Conclusions:
- Lipopolysaccharide (LPS) can act as a sufficient signal for differentiating macrophages into dendritic cell-like cells.
- LPS-induced differentiation enhances the antigen-presenting capabilities of macrophages.
